Kingfisher PLC has announced the purchase of 25,000 ordinary shares for cancellation on February 27, 2026, as part of its £300 million share repurchase programme. These shares were acquired from Goldman Sachs International at a volume-weighted average price of £3.6965, with the highest price paid being £3.7210 and the lowest £3.6750. This transaction brings the total shares purchased for cancellation under the fifth tranche of the programme to 19,088,200.
Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 27 February 2026 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from Goldman Sachs International ("GSI") as part of its £300 million share repurchase programme announced on 25 March 2025 (the "Programme"). All shares were purchased by Kingfisher from GSI as an "on-exchange" transaction subject to the rules of the London Stock Exchange.
Date of Purchase:
27 February 2026
Total number of shares purchased:
25,000
Volume Weighted Average price paid per share:
£3.6965
Highest price paid per share:
£3.7210
Lowest price paid per share:
£3.6750
To date, Kingfisher has purchased 19,088,200 ordinary shares in aggregate for cancellation from GSI in connection with the fifth tranche of the Programme. Kingfisher also previously purchased 17,932,871 ordinary shares in aggregate for cancellation from GSI,18,118,306 ordinary shares in aggregate for cancellation from BNP Paribas SA, 24,713,988 ordinary shares in aggregate for cancellation from GSI and 16,095,884 ordinary shares in aggregate for cancellation from Morgan Stanley & Co. International Plc in connection with its execution of the first, second, third and fourth tranches, respectively, of the Programme.
A schedule of individual trades carried out by GSI as principal in connection with the above purchases is set out below.
Schedule of Purchases - Aggregate Information
Trading Venue
Number of Shares
Volume Weighted Average Price paid per share
XLON
25,000
£3.6965
CHIX
0
£0.0000
BATE
0
£0.0000
TRQX
0
£0.0000
AQXE
0
£0.0000
Schedule of Purchases - Individual Transactions
Price GBP
Time of each trade on 27 Feb 2026 (GMT)
Trading Venue
Number of Shares
Transaction Reference Number
3.6970
09:11:19
XLON
121
1397849258469618
3.6970
09:11:19
XLON
1,167
1397849258469619
3.6960
09:12:10
XLON
3
1397849258469741
3.6980
09:13:16
XLON
998
1397849258469860
3.7020
09:41:05
XLON
998
1397849258471932
3.6840
10:10:23
XLON
914
1397849258474454
3.6810
10:27:40
XLON
945
1397849258475811
3.6820
10:46:32
XLON
938
1397849258477393
3.6790
11:05:28
XLON
576
1397849258478686
3.6790
11:05:28
XLON
451
1397849258478687
3.6750
11:30:40
XLON
748
1397849258480658
3.6750
11:30:40
XLON
83
1397849258480659
3.6750
11:30:40
XLON
88
1397849258480660
3.6840
12:08:18
XLON
999
1397849258483289
3.6820
12:33:35
XLON
1,021
1397849258484763
3.6850
12:55:53
XLON
458
1397849258486200
3.6850
12:55:53
XLON
35
1397849258486201
3.6850
12:55:53
XLON
53
1397849258486202
3.6900
13:12:34
XLON
909
1397849258487243
3.6860
13:27:14
XLON
324
1397849258488297
3.6860
13:27:14
XLON
579
1397849258488298
3.6920
13:50:43
XLON
844
1397849258491057
3.6930
14:10:35
XLON
899
1397849258492805
3.6930
14:23:14
XLON
985
1397849258493898
3.6960
14:35:09
XLON
1,039
1397849258498096
3.7020
14:46:12
XLON
1,008
1397849258501570
3.7050
14:59:18
XLON
1,088
1397849258505383
3.7090
15:09:11
XLON
938
1397849258507958
3.7020
15:20:39
XLON
921
1397849258510781
3.7150
15:37:52
XLON
633
1397849258514172
3.7150
15:37:52
XLON
368
1397849258514173
3.7140
15:49:52
XLON
907
1397849258516492
3.7180
16:06:10
XLON
893
1397849258520542
3.7180
16:06:10
XLON
106
1397849258520543
3.7210
16:17:15
XLON
956
1397849258524065
3.7140
16:25:02
XLON
1,007
1397849258526929
Contacts:
Tel:
Email:
Group Company Secretariat
+44 (0) 20 7372 8008
secretariat@kingfisher.com
Investor Relations
+44 (0) 20 7644 1082
investorenquiries@kingfisher.com
Treasury
+44 (0) 20 7372 8008
treasury@kingfisher.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
